|
Delayed
Nasdaq
16:00:00 2025-04-17 EDT
|
5-day change | 1st Jan Change | ||
| 8.540 USD | -.--% |
|
-.--% | - |
| 25-04-21 | Jazz Pharmaceuticals Completes $935 Million Acquisition of Chimerix | MT |
| 25-04-21 | Chimerix, Inc. Announces Alan Campion as the Chief Financial Officer | CI |
Company Valuation: Chimerix, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 124.6 | 302.5 | 558.5 | 163.8 | 85.56 | 313 |
| Change | - | 142.78% | 84.62% | -70.68% | -47.76% | 265.81% |
| Enterprise Value (EV) 1 | 11.98 | 226.5 | 487 | -51.18 | -95.46 | 182.5 |
| Change | - | 1,790.06% | 115.02% | -110.51% | -86.52% | 291.2% |
| P/E | -1x | -6.9x | -3.15x | 0.96x | -1.03x | -3.52x |
| PBR | 1.14x | 4.13x | 8.19x | 0.64x | 0.44x | 2.64x |
| PEG | - | 0.1x | -0x | -0x | 0x | -0.55x |
| Capitalization / Revenue | 9.95x | 56.3x | 282x | 4.84x | 264x | 1,476x |
| EV / Revenue | 0.96x | 42.2x | 246x | -1.51x | -295x | 861x |
| EV / EBITDA | -0.27x | -5.13x | -5.39x | 0.88x | 1.03x | -1.89x |
| EV / EBIT | -0.26x | -5.09x | -5.38x | 0.87x | 1.03x | -1.89x |
| EV / FCF | -0.49x | -10.9x | -11.6x | 2.5x | 2.47x | -4.14x |
| FCF Yield | -204% | -9.18% | -8.6% | 40% | 40.4% | -24.1% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -2.028 | -0.6999 | -2.04 | 1.94 | -0.93 | -0.99 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 12.52 | 5.372 | 1.979 | 33.82 | 0.324 | 0.212 |
| EBITDA 1 | -44.67 | -44.11 | -90.34 | -58.43 | -92.97 | -96.47 |
| EBIT 1 | -45.23 | -44.52 | -90.51 | -58.53 | -93.06 | -96.57 |
| Net income 1 | -112.6 | -43.52 | -173.2 | 172.2 | -82.1 | -88.39 |
| Net Debt 1 | -112.6 | -76.04 | -71.54 | -214.9 | -181 | -130.5 |
| Reference price 2 | 2.030 | 4.830 | 6.430 | 1.860 | 0.962 | 3.480 |
| Nbr of stocks (in thousands) | 61,382 | 62,634 | 86,862 | 88,045 | 88,891 | 89,936 |
| Announcement Date | 2/25/20 | 2/25/21 | 3/1/22 | 3/2/23 | 2/29/24 | 3/21/25 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 801M | |
| 20.97x | 7.35x | 14.98x | 1.41% | 70.42B | |
| 37.32x | 9.68x | 29.71x | 0.04% | 65.4B | |
| -17.15x | 7.14x | -8.98x | -.--% | 28.28B | |
| 30.86x | 6.62x | 17.71x | -.--% | 26.57B | |
| -78.62x | 14.69x | -70.84x | -.--% | 27.16B | |
| 27.31x | 5.12x | 17.18x | -.--% | 20.09B | |
| 59.78x | 22.25x | 45.14x | 0.25% | 20.61B | |
| 1692.68x | 39.78x | 868.6x | -.--% | 15.87B | |
| 17.35x | 5.16x | 12.03x | -.--% | 13.9B | |
| Average | 198.94x | 13.09x | 102.84x | 0.19% | 28.91B | |
| Weighted average by Cap. | 107.54x | 11.07x | 57.30x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CMRX Stock
- Valuation Chimerix, Inc.
Select your edition
All financial news and data tailored to specific country editions
